|
|||||
|
|
Reducing length of stay with the direct oral anti-coagulants in low and intermediate risk pulmonary embolism: a single center experience |
|
| Authors: | Filopei Jason Bondarsky Eric E Ehrlich Madeline Islam Marjan Bajpayee Gargi Pang Daniel Shujaat Adil Rowland John Steiger David J |
| Institution: | 1.Division of Pulmonary Critical Care and Sleep Medicine, Icahn School of Medicine, Mount Sinai Beth Israel, New York, NY, USA ;2.Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, NYU Langone, 301 East 17th Street, Suite 550, New York, NY, 10003, USA ;3.Divisions of Pulmonary and Critical Care Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, New York, USA ;4.Division of Cardiovascular Disease, Icahn School of Medicine, Mount Sinai Beth Israel, New York, NY, USA ;5.Icahn School of Medicine at Mount Sinai, New York, NY, USA ;6.Mount Sinai West, Icahn School of Medicine at Mount Sinai, New York, NY, USA ; |
| Abstract: | Journal of Thrombosis and Thrombolysis - Direct oral anti-coagulants (DOACs) reduce hospital length-of-stay (LOS) in patients with acute pulmonary embolism (PE) in clinical trials. There is a... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |